1. Home
  2. CNTB vs PSNL Comparison

CNTB vs PSNL Comparison

Compare CNTB & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • PSNL
  • Stock Information
  • Founded
  • CNTB 2012
  • PSNL 2011
  • Country
  • CNTB United States
  • PSNL United States
  • Employees
  • CNTB N/A
  • PSNL N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • PSNL Medical Specialities
  • Sector
  • CNTB Health Care
  • PSNL Health Care
  • Exchange
  • CNTB Nasdaq
  • PSNL Nasdaq
  • Market Cap
  • CNTB 68.5M
  • PSNL 321.1M
  • IPO Year
  • CNTB 2021
  • PSNL 2019
  • Fundamental
  • Price
  • CNTB $1.17
  • PSNL $5.19
  • Analyst Decision
  • CNTB Strong Buy
  • PSNL Strong Buy
  • Analyst Count
  • CNTB 1
  • PSNL 4
  • Target Price
  • CNTB $8.00
  • PSNL $6.81
  • AVG Volume (30 Days)
  • CNTB 24.6K
  • PSNL 439.4K
  • Earning Date
  • CNTB 09-05-2024
  • PSNL 11-06-2024
  • Dividend Yield
  • CNTB N/A
  • PSNL N/A
  • EPS Growth
  • CNTB N/A
  • PSNL N/A
  • EPS
  • CNTB N/A
  • PSNL N/A
  • Revenue
  • CNTB $24,116,000.00
  • PSNL $80,027,000.00
  • Revenue This Year
  • CNTB N/A
  • PSNL $10.85
  • Revenue Next Year
  • CNTB $63.90
  • PSNL $8.77
  • P/E Ratio
  • CNTB N/A
  • PSNL N/A
  • Revenue Growth
  • CNTB N/A
  • PSNL 19.20
  • 52 Week Low
  • CNTB $0.68
  • PSNL $0.89
  • 52 Week High
  • CNTB $2.84
  • PSNL $7.20
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 44.02
  • PSNL 56.29
  • Support Level
  • CNTB $1.18
  • PSNL $4.54
  • Resistance Level
  • CNTB $1.26
  • PSNL $5.35
  • Average True Range (ATR)
  • CNTB 0.07
  • PSNL 0.30
  • MACD
  • CNTB -0.01
  • PSNL 0.05
  • Stochastic Oscillator
  • CNTB 13.59
  • PSNL 84.71

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Share on Social Networks: